Amethyst Radiation Oncology Expert Featured On Zena Platform

Dr David Kuczer, radiation oncology expert with Amethyst Group, has been interviewed by leading Serbian news platform Zena, talking about the role that radiotherapy has to play in breast cancer treatments.

Speaking to the news source, Dr Kuczer explained that all treatments are individually designed to suit each specific patient, using the most innovative and up-to-date knowledge to deliver optimal results, medically and aesthetically.

The interdisciplinary team at Amethyst’s Department of Tumours works collaboratively to come up with uniquely tailored approaches to patient care. From Dr Kuczer’s perspective, he believes it’s most important to spend time with patients while working on idea exchanges with colleagues and finding the best treatment options on a case by case basis.

He said: “Thanks to modern technology, the therapy has been reduced from about 30 treatments during six weeks to five to 20 treatments over the course of one to four weeks, depending on the individual case. The sessions last ten minutes and are performed on an outpatient basis.”

Around 50 per cent of all breast cancer patients will have to have radiotherapy, with high doses of radiation directed towards tumours to damage diseased cell DNA sufficiently to prevent multiplication. Once the tumour cells die, they’re broken down by the body.

This way of working means that tissue affected by the tumour can be removed, protecting the entirety of the breast and removing the need for complete removal. Recurrence is also prevented through the elimination of microscopic tumour remnants.

Finding innovative ways of treating cancer is a must, given that the disease is the leading cause of death around the world, with nearly ten million fatalities each year.

Here at Amethyst Group, we work tirelessly to identify new treatment methods to kill and eliminate malignant cells while preserving healthy tissue. To find out more, get in touch with the team today.